tirzepatide fda approval https://investor.lilly.com/news-releases/news-release-details/zepbound- tirzepatide-most-prescribed-weight-management “Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved a label expansion for Zepbound Tirzepatide (Mounjaro) Wins FDA Approval
Pay in 4 interest-free payments of $6.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 15 - Oct 20






![Mounjaro Eye Side Effects Lawsuit [2026 Update]](https://www.robertkinglawfirm.com/wp-content/uploads/2024/08/mounjaro-eye-side-effects-e1724082833782.webp)









![Zepbound Dry Eye Syndrome: An Authoritative Patient Guide [2025]](https://classactionlawyertn.com/wp-content/uploads/2025/11/mounjaro-vision-probloms.webp)



&srotate=0)







